FORMA THERAPEUTICS HLDGS INC's ticker is FMTX and the CUSIP is 34633R104. A total of 93 filers reported holding FORMA THERAPEUTICS HLDGS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,589,000 | +810.3% | 280,183 | +214.2% | 0.00% | – |
| Q2 2022 | $614,000 | -26.0% | 89,181 | 0.0% | 0.00% | – |
| Q1 2022 | $830,000 | +14.8% | 89,181 | +75.3% | 0.00% | – |
| Q4 2021 | $723,000 | -86.4% | 50,863 | -76.1% | 0.00% | -100.0% |
| Q2 2021 | $5,303,000 | -48.8% | 213,044 | -42.4% | 0.00% | -50.0% |
| Q1 2021 | $10,359,000 | -80.2% | 369,640 | -75.3% | 0.00% | -80.0% |
| Q4 2020 | $52,218,000 | -42.3% | 1,496,246 | -18.8% | 0.01% | -47.4% |
| Q3 2020 | $90,536,000 | -8.0% | 1,842,611 | -15.3% | 0.02% | -13.6% |
| Q2 2020 | $98,441,000 | – | 2,175,113 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,565,526 | $36,305,000 | 5.70% |
| Cormorant Asset Management, LP | 4,720,495 | $109,468,000 | 4.45% |
| Logos Global Management LP | 2,115,000 | $49,047,000 | 3.54% |
| RA Capital Management | 9,011,651 | $208,980,000 | 2.90% |
| Opaleye Management Inc. | 182,950 | $4,243,000 | 0.79% |
| Artal Group S.A. | 1,000,000 | $23,190,000 | 0.52% |
| HighVista Strategies LLC | 26,711 | $619,000 | 0.41% |
| Integral Health Asset Management, LLC | 60,000 | $1,391,000 | 0.40% |
| HHLR ADVISORS, LTD. | 1,100,000 | $25,509,000 | 0.33% |
| Baker Brothers Advisors | 2,024,876 | $46,957,000 | 0.21% |